Roic AI
Solutions
API Docs
MCP
Pricing
Discord
Resources
Toggle navigation menu
Company Search
⌘
K
Toggle theme
Toggle theme
Login
Sign up
Odonate Therapeutics, Inc.
O
OTC:ODTC
OTC Markets
- -
USD
- -
- -
Odonate Therapeutics, Inc.
OTC:ODTC
(OTC Markets)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
2015
2016
2017
2018
2019
2020
2021
2022
2023
TTM
USD
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
-470.24
-9,181.55
-97,452.38
-266,347.31
-279,562.5
-262,136.93
-142,027.03
- -
- -
-142,027.03
Basic EPS, GAAP
-491.07
-5,157.74
-77,205.36
-206,589.82
-242,010
-235,605.81
-157,486.49
- -
- -
-157,486.49
Free Cash Flow per Basic Share
- -
2,354.17
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
330.36
6,794.64
583,279.76
371,269.46
405,750
282,458.51
123,209.98
- -
303,710.67
123,209.98
Book Value per Share
330.36
6,794.64
583,279.76
371,269.46
405,750
282,458.51
123,209.98
- -
303,710.67
123,209.98
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
-3
-33
-89
-112
-126
-68
43
7
-68
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
22.44
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
2
195
122
159
133
59
48
57
59
Working Capital
- -
- -
- -
- -
2
5
4
2
2
4
LT Debt
- -
2
196
124
162
136
59
101
108
59
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
-0.59
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
-257.73
-33.03
-55.6
-78.12
-84.67
-69.92
53.64
7.01
-69.92
Return on Common Equity (%)
Capital Structure
USD
•
in mil. unless spec.
Jun'21
Sep'21
Dec'21
ST Debt
1
1
1
LT Borrowings
- -
- -
- -
LT Finance Leases
4
4
4
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
- -
- -
Market Capitalization
134
112
52
Working Capital
USD
•
in mil. unless spec.
Jun'21
Sep'21
Dec'21
Total Current Assets
112
100
75
Cash, Cash Equivalents & STI
110
95
69
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
30
30
16
Payables & Accruals
26
29
15
ST Debt
1
1
1
Deferred Revenue
- -
- -
- -
Growth Rates
USD
•
in mil. unless spec.
(avg. rate of change)
10 years
5 years
1 year
Total Equity
- -
7.13%
7.21%
Free Cash Flow
- -
61.77%
386.91%
Net Income, GAAP
- -
-50.61%
-82.94%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -
Quarterly Revenue
USD
•
in mil. unless spec.
Year
Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
Quarterly Earnings Per Share
USD
•
in mil. unless spec.
Year
Q1
Q2
Q3
Q4
FY
2021
-70,203.74
-45,769.23
-29,099.79
- -
-142,027.03
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
Quarterly Dividends Per Share
USD
•
in mil. unless spec.
Year
Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
Similar Companies
Business
Summary
Financials
Ratios
Charts
Classic View
Statistics
Stock Splits
Legends:
Stock price
Beta (1.0 Market)
% total return 10/23
Stock
S&P 500
1Y
- -
14.20
3Y
- -
81.12
5Y
- -
68.34